{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-004477","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.581980+00:00","generated_at":"2026-06-13T15:52:39.824498+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aethlon Medical reports FY2023 cash $14.5M, operating expenses $12.47M; advances Hemopurifier trials","bullets":["Cash balance $14.5M at March 31, 2023; operating expenses $12.47M, up $1.76M from $10.71M in FY2022.","COVID-19 ICU trial in India: one patient treated; second hospital (MAMC) got ethics approval in May 2023.","Oncology clinical trial planned in Australia: safety/feasibility/dose-finding in solid tumors failing anti-PD-1 antibodies.","New organ transplant initiative: testing Hemopurifier in machine perfusion to remove viruses/exosomes from harvested organs."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-004477","json":"https://secwatch.observer/filing/0001683168-23-004477.json","markdown":"https://secwatch.observer/filing/0001683168-23-004477.md","text":"https://secwatch.observer/filing/0001683168-23-004477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/0001683168-23-004477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:52:39.824498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bcaed69102c9cea62344ec0e7ce86d53e003865e","claim":"AETHLON MEDICAL INC reported financial results for fiscal year ended March 31, 2023.","evidence_excerpt":"issued a press release announcing its financial results for the fiscal year ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316823004477/0001683168-23-004477-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended March 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}